Topic Highlight
Copyright ©The Author(s) 2015.
World J Gastroenterol. Nov 7, 2015; 21(41): 11767-11776
Published online Nov 7, 2015. doi: 10.3748/wjg.v21.i41.11767
Table 2 Retrospective studies of patients with unresected liver metastases
Ref.Patients without extrahepatic metastases, nThe extent of liver involvementMedian overall survival (mo)Treatments
Yamamura et al[41], 1997 (n = 73)67Metastases in one lobe13Chemotherapy (chemotherapy did not significantly affect survival in multivariate analysis)
Less than four metastases in both lobes12
More than five metastases in both lobes6
Stangl et al[39], 1994189 ≤ 25%11.1No treatment
> 25%6.3
Chang et al[38], 1989 (n = 67)4915.1Floxuridine (hepatic arterial or intravenously)
< 25%23.8
25%-75%14.8
> 75%7.3
Arnaud et al[40], 1984 (n = 56)(not specified)One lobe17NA
Both lobes8.23
Johnson et al[42], 198151Solitary liver metastasis (n = 12)18NA
Multiple metastases in one lobe (n = 6)7
Multiple metastases in both lobes (n = 33)8